The Center for Mesoscale Mapping (CMM) is driving the convergence of microscopic and macroscopic imaging for human translational neuroscience — by developing and applying the next generation of imaging tools to study mesoscopic events in the human brain in both the spatial and the temporal realms.

An NIBIB P41-funded national resource, the CMM encompasses projects with Collaborators and Service Users. Our Collaborators, through a dynamic “push-pull” relationship, provide us with unique problems that drive our development of tools to study mesoscopic events (“push”). At the same time, they guide us in the design and optimization of our toolbox for practical use in a variety of normal and disease settings (“pull”).

Our Service Users utilize the tools to better understand the human neural systems and particularly human disease states ranging from multiple sclerosis to Alzheimer’s disease to depression and schizophrenia — thus ultimately helping improve care.

CMM director Bruce Rosen offers an overview of the Center and its work in the video below. If you have any questions about the CMM, please don’t hesitate to email us.